These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 13969508)

  • 1. [Action of different inhibitors of L-DOPA decarboxylase on the water ration, diuresis and urinary sodium and potassium elimination in rats].
    BARRE N; CAHN J; HEROLD M
    C R Seances Soc Biol Fil; 1962; 156():1807-9. PubMed ID: 13969508
    [No Abstract]   [Full Text] [Related]  

  • 2. [ACTION OF 5-HTP/DOPA DECARBOXYLASE INHIBITORS ON DIURESIS, URINARY ELECTROLYTES AND RELEASE OF THE ANTIDIURETIC HORMONE].
    CAHN J; HEROLD M; BARRE N
    C R Seances Soc Biol Fil; 1964; 158():1331-5. PubMed ID: 14210566
    [No Abstract]   [Full Text] [Related]  

  • 3. [Action of some inhibitors of L-DOPA decarboxylase on the duration of barbiturate narcosis in the mouse].
    HEROLD M; CAHN J; HELBECQUE C; LASJAUNIAS T; JULLIARD AM
    C R Seances Soc Biol Fil; 1962; 156():1270-2. PubMed ID: 13961113
    [No Abstract]   [Full Text] [Related]  

  • 4. [ACTION OF CERTAIN L-DOPA/5-HTP DECARBOXYLASE INHIBITORS ON HYPOTHALAMO-HYPOPHYIAL NEUROSECRETION IN THE RAT].
    SOULAIRAC A; SOULAIRAC ML
    C R Seances Soc Biol Fil; 1964; 158():1445-7. PubMed ID: 14250544
    [No Abstract]   [Full Text] [Related]  

  • 5. [L-DOPA/5HTP DECARBOXYLASE INHIBITORS: PHARMACOLOGICAL PROPERTIES. THERAPEUTIC INDICATIONS].
    CAHN J; HEROLD M
    Agressologie; 1963; 11():375-84. PubMed ID: 14087222
    [No Abstract]   [Full Text] [Related]  

  • 6. Inhibition of decarboxylase and levels of dopa and 3-O-methyldopa: a comparative study of benserazide versus carbidopa in rodents and of Madopar standard versus Madopar HBS in volunteers.
    Da Prada M; Kettler R; Zürcher G; Schaffner R; Haefely WE
    Eur Neurol; 1987; 27 Suppl 1():9-20. PubMed ID: 3123242
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of DOPA accumulation by rat brain at critical L-DOPA circulating concentrations.
    Horst WD; Bautz G; Renyi E; Spirt N
    Adv Neurol; 1974; 5():369-73. PubMed ID: 4440584
    [No Abstract]   [Full Text] [Related]  

  • 8. [Progress in the therapy of parkinsonism with L-dopa: inhibition of dopa decarboxylase].
    Nurzia A
    Clin Ter; 1975 Feb; 72(3):289-95. PubMed ID: 1132216
    [No Abstract]   [Full Text] [Related]  

  • 9. [ACTION OF DIFFERENT INHIBITORS OF L-DOPA-5-HTP DECARBOXYLASE ON AN INDUCED HYPERTHERMIA OF CENTRAL ORIGIN].
    HELBECQUE C; JUILLARD AM; HEROLD M; CAHN J
    C R Seances Soc Biol Fil; 1963 Oct; 157():996-9. PubMed ID: 14092126
    [No Abstract]   [Full Text] [Related]  

  • 10. The parkinsonian neurotoxin 1-methyl-4-phenylpyridinium (MPP(+)) mediates release of l-3,4-dihydroxyphenylalanine (l-DOPA) and inhibition of l-DOPA decarboxylase in the rat striatum: a microdialysis study.
    Foster SB; Wrona MZ; Han J; Dryhurst G
    Chem Res Toxicol; 2003 Oct; 16(10):1372-84. PubMed ID: 14565778
    [TBL] [Abstract][Full Text] [Related]  

  • 11. gamma-L-glutamyl-L-DOPA inhibits Na(+)-phosphate cotransport across renal brush border membranes and increases renal excretion of phosphate.
    de Toledo FG; Thompson MA; Bolliger C; Tyce GM; Dousa TP
    Kidney Int; 1999 May; 55(5):1832-42. PubMed ID: 10231445
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Action of some DOPA decarboxylase inhibitors with reference to different types of convulsions].
    HEROLD M; CAHN J; HELBECQUE C; KABACOFF O
    C R Seances Soc Biol Fil; 1962; 156():1273-6. PubMed ID: 13954030
    [No Abstract]   [Full Text] [Related]  

  • 13. [Action of different inhibitors of L-DOPA 5 HTP decarboxylase on insulin hypoglycemia in the rat].
    CAHN J; HEROLD M; BARRE N
    C R Seances Soc Biol Fil; 1963 Jul; 157():501-3. PubMed ID: 14017720
    [No Abstract]   [Full Text] [Related]  

  • 14. Inhibition of human and rat hepatic aminotransferase activity with L-3,4-dihydroxyphenylalanine by inhibitors of peripheral aromatic amino acid decarboxylase.
    Waterhouse MJ; Chia YC; Lees GJ
    Mol Pharmacol; 1979 Jan; 15(1):108-14. PubMed ID: 423884
    [No Abstract]   [Full Text] [Related]  

  • 15. [Comparative effects of different inhibitors of L-DOPA decarboxylase in the rat and the mouse].
    CAHN J; HEROLD M; HELBECQUE C; LASJAUNIAS T; JUILLARD AM
    C R Seances Soc Biol Fil; 1962; 156():1094-8. PubMed ID: 14017721
    [No Abstract]   [Full Text] [Related]  

  • 16. β-asarone and levodopa coadministration increases striatal levels of dopamine and levodopa and improves behavioral competence in Parkinson's rat by enhancing dopa decarboxylase activity.
    Huang L; Deng M; Zhang S; Lu S; Gui X; Fang Y
    Biomed Pharmacother; 2017 Oct; 94():666-678. PubMed ID: 28787702
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Catecholaminergic neuronal pathways in homeostatic control of blood circulating mass].
    Zamboni P; Daniele E
    Boll Soc Ital Biol Sper; 1980 Dec; 56(24):2575-81. PubMed ID: 6110430
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Studies on dopa decarboxylase inhibitors in vivo by use of C14-carboxyl-labeled dopa.
    HANSSON E; CLARK WG
    Proc Soc Exp Biol Med; 1962 Dec; 111():793-8. PubMed ID: 13952652
    [No Abstract]   [Full Text] [Related]  

  • 19. [Effect of the ingestion of water on thirst and diuresis].
    Zamboni P; Siro-Brigiani G
    Boll Soc Ital Biol Sper; 1966 Jul; 42(14):931-3. PubMed ID: 5967948
    [No Abstract]   [Full Text] [Related]  

  • 20. The timing of administration, dose dependence and efficacy of dopa decarboxylase inhibitors on the reversal of motor disability produced by L-DOPA in the MPTP-treated common marmoset.
    Tayarani-Binazir KA; Jackson MJ; Fisher R; Zoubiane G; Rose S; Jenner P
    Eur J Pharmacol; 2010 Jun; 635(1-3):109-16. PubMed ID: 20303948
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.